Northern Trust’s CARGO Therapeutics CRGX Stock Holding History

Northern Trust’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-295,331	Closed	-$1.22M	–	4451
2025 Q2	$1.22M	Sell	295,331 -5,371	-2%	-$23K	﹤0.01%	3284
2025 Q1	$1.22M	Sell	300,702 -6,841	-2%	-$45.8K	﹤0.01%	3193
2024 Q4	$4.43M	Buy	307,543 +9,278	+3%	+$168K	﹤0.01%	2575
2024 Q3	$5.5M	Buy	298,265 +124,062	+71%	+$2.22M	﹤0.01%	2418
2024 Q2	$2.86M	Sell	174,203 -6,125	-3%	-$116K	﹤0.01%	2708
2024 Q1	$4.02M	Buy	180,328 +142,431	+376%	+$3.39M	﹤0.01%	2599
2023 Q4	$877K	Buy	+37,897	New	+$643K	﹤0.01%	3355

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northern Trust's CRGX Position: Q3 2025 in Review

Northern Trust sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 295,331 shares — an estimated $1.22M sold.

Northern Trust first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $5.5M in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Northern Trust reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Northern Trust sold 295,331 CARGO Therapeutics shares in Q3 2025, an estimated $1.22M.
Northern Trust first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Northern Trust's CARGO Therapeutics position peaked at $5.5M in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.